Nerol as an Anti-quorum sensing and Therapeutic Agent against Acinetobacter baumannii Pneumonia
Ontology highlight
ABSTRACT: Nerol subinhibitory concentrations block A. baumannii quorum sensing, inhibiting AHL, biofilm formation, motility, and EPS production. Proteomics validated these phenotypes, showing synchronous downregulation of key virulence proteins including BfmS and MacB. ITC confirmed its binding to BfmS disrupts the BfmRS two-component system. In a mouse pneumonia model, it significantly reduced lung bacterial load, blocked the NF-κB/MAPK axis, decreased inflammatory expression, restored lung tissue structure, and showed no hepatotoxicity. This provides a safe, non-antibiotic strategy for treating carbapenem-resistant Acinetobacter baumannii pneumonia.
ORGANISM(S): Acinetobacter Baumannii Atcc 19606 = Cip 70.34 = Jcm 6841
SUBMITTER:
Hong Zeng
PROVIDER: PXD073438 | iProX | Fri Jan 23 00:00:00 GMT 2026
REPOSITORIES: iProX
ACCESS DATA